WEEKLY NEWSLETTER

Health's Top Stories
Get a weekly look at the most popular stories on Health.com.

Leucovorin


content provided by Healthwise

Examples

Generic NameBrand Name
leucovorin

Leucovorin comes in intravenous (IV), intramuscular (IM) injection (shot), and oral form.

How It Works

Leucovorin is a derivative of folic acid. Leucovorin works differently depending on whether it is used with methotrexate (MTX) or fluorouracil (5-FU).

  • Methotrexate: Leucovorin is given to "rescue" the gastrointestinal lining and bone marrow cells from MTX toxicity. Most of the complications and side effects of methotrexate can be either prevented or treated by using leucovorin, which is usually given 24 hours after methotrexate.
  • Fluorouracil: Leucovorin increases the effectiveness of 5-FU, increasing the anticancer effect.

Why It Is Used

Leucovorin is used with either methotrexate (MTX) for the treatment of ectopic pregnancy or fluorouracil (5-FU) for colon or breast cancer.

How Well It Works

Most of the complications and side effects of methotrexate can be either prevented or treated by using leucovorin, which is usually given 24 hours after the methotrexate is given.

Leucovorin enhances the binding of fluorouracil (5-FU) and prolongs the life span of 5-FU, increasing the anticancer effect.1

Side Effects

Leucovorin is very well tolerated and has almost no side effects of its own.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Leucovorin generally decreases the severity of side effects of MTX. It can increase the severity of the side effects of 5-FU when used with that medication.

Leucovorin should be administered only under the supervision of a medical oncologist.

Complete the new medication information form (PDF)Click here to view a form.(What is a PDF document?) to help you understand this medication.

References

Citations

  1. Meyerhardt JA, Mayer RJ (2005). Systemic therapy for colorectal cancer. New England Journal of Medicine, 352(5): 476–486.

Credits

AuthorBets Davis, MFA
EditorSusan Van Houten, RN, BSN, MBA
Associate EditorPat Truman, MATC
Primary Medical ReviewerAnne C. Poinier, MD

- Internal Medicine
Specialist Medical ReviewerArvydas D. Vanagunas, MD

- Gastroenterology
Last UpdatedDecember 1, 2006

Last Updated: December 1, 2006
Author:
Bets Davis, MFA
Medical Review:
Anne C. Poinier, MD - Internal Medicine

Arvydas D. Vanagunas, MD - Gastroenterology


© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.



This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.